| Gene symbol | CD33 | Synonyms | CD33rSiglec, SIGLEC-3, SIGLEC3, p67 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.41 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD33 molecule | ||||
| GTO ID | GTC2648 |
| Trial ID | NCT04835519 |
| Disease | Leukemia | Acute Myeloid Leukemia |
| Altered gene | CD33 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD33 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia |
| Year | 2021 |
| Country | China |
| Company sponsor | Beijing Boren Hospital |
| Other ID(s) | BRYY-IIT-LCYJ-2021-003 |
| Cohort 1 | |||||||||||
|
|||||||||||